Matrix metalloproteinases: Targets for doxycycline to prevent the vascular alterations of hypertension

Pharmacological Research

Volumn 64, Issue 6, 2011, Pages 567-572

  Castro, Michele M ^a   Tanus Santos, Jose E ^b   Gerlach, Raquel F ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Doxycycline; Hypertension; Matrix metalloproteinases; Vascular remodeling

Indexed keywords

DOXYCYCLINE; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE 14; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ANTIHYPERTENSIVE ACTIVITY; ARTERIAL STIFFNESS; CARDIOVASCULAR DISEASE; DISEASE MODEL; DOWN REGULATION; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HEART PROTECTION; HUMAN; HYPERTENSION; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; BLOOD VESSELS; CARDIOTONIC AGENTS; DOXYCYCLINE; HUMANS; HYPERTENSION; MATRIX METALLOPROTEINASES; PROTEASE INHIBITORS;

EID: 80054110244     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2011.04.002     Document Type: Review

References (78)

1. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo Jr. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure Hypertension 42 2003 1206 1252 (Pubitemid 37553153)
2. H.D. Intengan, and E.L. Schiffrin Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants Hypertension 36 2000 312 318
3. H.D. Intengan, and E.L. Schiffrin Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis Hypertension 38 2001 581 587
4. D. Dajnowiec, and B.L. Langille Arterial adaptations to chronic changes in haemodynamic function: coupling vasomotor tone to structural remodelling Clin Sci 113 2007 15 23 (Pubitemid 47066021)
5. J.D. Humphrey Mechanisms of arterial remodeling in hypertension: coupled roles of wall shear and intramural stress Hypertension 52 August (2) 2008 195 200
6. M.J. Mulvany Small artery remodeling and significance in the development of hypertension News Physiol Sci 17 2002 105 109
7. C.A. Lemarie, P.L. Tharaux, and S. Lehoux Extracellular matrix alterations in hypertensive vascular remodeling J Mol Cell Cardiol 48 March (3) 2010 433 439
8. J.D. Raffetto, and R.A. Khalil Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease Biochem Pharmacol 75 2008 346 359 (Pubitemid 350298459)
9. J. Gross, and C.M. Lapiere Collagenolytic activity in amphibian tissues: a tissue culture assay Proc Natl Acad Sci U S A 48 1962 1014 1022
10. H. Nagase, R. Visse, and G. Murphy Structure and function of matrix metalloproteinases and TIMPs Cardiovasc Res 69 3 2006 562 573 (Pubitemid 43139720)
11. V.A. Belo, D.C. Souza-Costa, C.M. Lana, F.L. Caputo, A.M. Marcaccini, and R.F. Gerlach Assessment of matrix metalloproteinase (mmp)-2, mmp-8, mmp-9, and their inhibitors, the tissue inhibitors of metalloproteinase (timp)-1 and timp-2 in obese children and adolescents Clin Biochem 42 2009 984 990
12. F.M. Goncalves, A.L. Jacob-Ferreira, V.A. Gomes, A. Casella-Filho, A.C. Chagas, and A.M. Marcaccini Increased circulating levels of matrix metalloproteinase (mmp)-8, mmp-9, and pro-inflammatory markers in patients with metabolic syndrome Clin Chim Acta 403 2009 173 177
13. A.C. Palei, V.C. Sandrim, R.C. Cavalli, and J.E. Tanus-Santos Comparative assessment of matrix metalloproteinase (mmp)-2 and mmp-9, and their inhibitors, tissue inhibitors of metalloproteinase (timp)-1 and timp-2 in preeclampsia and gestational hypertension Clin Biochem 41 2008 875 880
14. P. Brassard, F. Amiri, and E.L. Schiffrin Combined angiotensin ii type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries Hypertension 46 2005 598 606 (Pubitemid 41376842)
15. C.S. Ceron, M.M. Castro, E. Rizzi, M.F. Montenegro, V. Fontana, and M.C. Salgado Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension Br J Pharmacol 160 2010 77 87
16. M. Flamant, S. Placier, C. Dubroca, B. Esposito, I. Lopes, and C. Chatziantoniou Role of matrix metalloproteinases in early hypertensive vascular remodeling Hypertension 50 2007 212 218 (Pubitemid 46986043)
17. M.L. Martinez, M.M. Castro, E. Rizzi, K. Fernandes, C. Demacq, and L.M. Bendhack Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats Eur J Pharmacol 591 2008 224 230
18. J.M. Ruddy, J.A. Jones, R.E. Stroud, R. Mukherjee, F.G. Spinale, and J.S. Ikonomidis Differential effects of mechanical and biological stimuli on matrix metalloproteinase promoter activation in the thoracic aorta Circulation 120 2009 S262 S268
19. W. Bode, and K. Maskos Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases Biol Chem 384 2003 863 872 (Pubitemid 36874500)
20. C.E. Brinckerhoff, and L.M. Matrisian Matrix metalloproteinases: a tail of a frog that became a prince Nat Rev Mol Cell Biol 3 2002 207 214
21. R. Visse, and H. Nagase Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry Circ Res 92 2003 827 839 (Pubitemid 36542523)
22. H. Nagase, and J.F. Woessner Jr. Matrix metalloproteinases J Biol Chem 274 1999 21491 21494
23. S.W. Watts, C. Rondelli, K. Thakali, X. Li, B. Uhal, and M.H. Pervaiz Morphological and biochemical characterization of remodeling in aorta and vena cava of doca-salt hypertensive rats Am J Physiol Heart Circ Physiol 292 May (5) 2007 H2438 H2448 (Pubitemid 47084627)
24. G. Derosa, A. D'Angelo, L. Ciccarelli, M.N. Piccinni, F. Pricolo, and S. Salvadeo Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension Endothelium 13 2006 227 231 (Pubitemid 44110588)
25. H.E. Van Wart, and H. Birkedal-Hansen The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family Proc Natl Acad Sci U S A 87 1990 5578 5582
26. T. Okamoto, T. Akaike, T. Sawa, Y. Miyamoto, A. van der Vliet, and H. Maeda Activation of matrix metalloproteinases by peroxynitrite-induced protein s-glutathiolation via disulfide s-oxide formation J Biol Chem 276 31 2001 29596 29602
27. S. Viappiani, A.C. Nicolescu, A. Holt, G. Sawicki, B.D. Crawford, and H. Leon Activation and modulation of 72 kDa matrix metalloproteinase-2 by peroxynitrite and glutathione Biochem Pharmacol 77 2009 826 834
28. R. Schulz Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches Annu Rev Pharmacol Toxicol 47 2007 211 242
29. S.M. Arribas, A. Hinek, and M.C. Gonzalez Elastic fibres and vascular structure in hypertension Pharmacol Ther 111 2006 771 791 (Pubitemid 44118433)
30. D. Rizzoni, M.L. Muiesan, E. Porteri, C. De Ciuceis, G.E. Boari, and M. Salvetti Vascular remodeling, macro- and microvessels: therapeutic implications Blood Press 18 2009 242 246
31. M. Flamant, S. Placier, C. Dubroca, B. Esposito, I. Lopes, and C. Chatziantoniou Role of matrix metalloproteinases in early hypertensive vascular remodeling Hypertension 50 July (1) 2007 212 218 (Pubitemid 46986043)
32. Yasmin, C.M. McEniery, S. Wallace, Z. Dakham, P. Pulsalkar, and K. Maki-Petaja Matrix metalloproteinase-9 (mmp-9), mmp-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness Arterioscler Thromb Vasc Biol 25 February (2) 2005 372
33. S.H. Ahmed, L.L. Clark, W.R. Pennington, C.S. Webb, D.D. Bonnema, and A.H. Leonardi Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease Circulation 113 May (17) 2006 2089 2096
34. C. Bouvet, L.A. Gilbert, D. Girardot, D. deBlois, and P. Moreau Different involvement of extracellular matrix components in small and large arteries during chronic no synthase inhibition Hypertension 45 2005 432 437 (Pubitemid 40315814)
35. S. Lehoux, C.A. Lemarie, B. Esposito, H.R. Lijnen, and A. Tedgui Pressure-induced matrix metalloproteinase-9 contributes to early hypertensive remodeling Circulation 109 8 2004 1041 1047 (Pubitemid 38282859)
36. M.M. Castro, E. Rizzi, L. Figueiredo-Lopes, K. Fernandes, L.M. Bendhack, and D.L. Pitol Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats Atherosclerosis 198 June (2) 2008 320 331 (Pubitemid 351707391)
37. M.L. Martinez, L.F. Lopes, E.B. Coelho, F. Nobre, J.B. Rocha, and R.F. Gerlach Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension J Cardiovasc Pharmacol 47 2006 117 122 (Pubitemid 44378234)
38. A.C. Newby Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates Cardiovasc Res 69 February (3) 2006 614 624 (Pubitemid 43140745)
39. Z.S. Galis, and J.J. Khatri Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly Circ Res 90 2002 251 262 (Pubitemid 34633925)
40. C. Johnson, and Z.S. Galis Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization Arterioscler Thromb Vasc Biol 24 January (1) 2004 54 60 (Pubitemid 38082411)
41. N. Zempo, N. Koyama, R.D. Kenagy, H.J. Lea, and A.W. Clowes Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor Arterioscler Thromb Vasc Biol 16 1996 28 33 (Pubitemid 26026928)
42. A. Cho, and M.A. Reidy Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury Circ Res 91 2002 845 851 (Pubitemid 35285083)
43. M.P. Bendeck, M. Conte, M. Zhang, N. Nili, B.H. Strauss, and S.M. Farwell Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury Am J Pathol 160 2002 1089 1095 (Pubitemid 34224595)
44. S. Lehoux, Y. Castier, and A. Tedgui Molecular mechanisms of the vascular responses to haemodynamic forces J Intern Med 259 2006 381 392 (Pubitemid 43384229)
45. S. Lehoux, and A. Tedgui Signal transduction of mechanical stresses in the vascular wall Hypertension 32 1998 338 345 (Pubitemid 28376494)
46. H.M. Lee, S.G. Ciancio, G. Tuter, M.E. Ryan, E. Komaroff, and L.M. Golub Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug J Periodontol 75 2004 453 463 (Pubitemid 38461128)
47. A.K. Chow, J. Cena, and R. Schulz Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature Br J Pharmacol 152 2007 189 205 (Pubitemid 47517601)
48. L.M. Golub, N.S. Ramamurthy, T.F. McNamara, R.A. Greenwald, and B.R. Rifkin Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs Crit Rev Oral Biol Med 2 1991 297 321
49. F.J. Villarreal, M. Griffin, J. Omens, W. Dillmann, J. Nguyen, and J. Covell Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling Circulation 108 September (12) 2003 1487 1492 (Pubitemid 37176456)
50. N. Yaras, M. Sariahmetoglu, A. Bilginoglu, A. Aydemir-Koksoy, A. Onay-Besikci, and B. Turan Protective action of doxycycline against diabetic cardiomyopathy in rats Br J Pharmacol 155 December (8) 2008 1174 1184
51. E. Rizzi, M.M. Castro, C.M. Prado, C.A. Silva, R. Fazan Jr., and M.A. Rossi Matrix metalloproteinase inhibition improves cardiac dysfunction and remodeling in 2-kidney, 1-clip hypertension J Card Fail 16 July (7) 2010 599 608
52. L.M. Golub, N. Ramamurthy, T.F. McNamara, B. Gomes, M. Wolff, and A. Casino Tetracyclines inhibit tissue collagenase activity. A new mechanism in the treatment of periodontal disease J Periodontal Res 19 1984 651 655 (Pubitemid 15168777)
53. L.M. Golub, H.M. Lee, M.E. Ryan, W.V. Giannobile, J. Payne, and T. Sorsa Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms Adv Dent Res 12 1998 12 26
54. C. Jonat, F.Z. Chung, and V.M. Baragi Transcriptional downregulation of stromelysin by tetracycline J Cell Biochem 60 1996 341 347 (Pubitemid 26090502)
55. M.M. Castro, E. Rizzi, C.M. Prado, M.A. Rossi, J.E. Tanus-Santos, and R.F. Gerlach Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling Matrix Biol 29 2010 194 201
56. S. Filippov, G.C. Koenig, T.H. Chun, K.B. Hotary, I. Ota, and T.H. Bugge Mt1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells J Exp Med 202 2005 663 671 (Pubitemid 41248417)
57. D.A. Guimaraes, E. Rizzi, C.S. Ceron, A.M. Oliveira, D.M. Oliveira, M.M. Castro, C.R. Tirapelli, R.F. Gerlach, and J.E. Tanus-Santos Doxycycline dose-dependently inhibits MMP-2-mediated vascular changes in 2K1C hypertension Basic Clin Pharmacol Toxicol 108 2011 318 325
58. M.A. Moses, J. Harper, and J. Folkman Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for mmps N Engl J Med 354 2006 2621 2622 (Pubitemid 43882375)
59. C. Fernandez-Patron, M.W. Radomski, and S.T. Davidge Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor Circ Res 85 1999 906 911 (Pubitemid 29534165)
60. C. Fernandez-Patron, K.G. Stewart, Y. Zhang, E. Koivunen, M.W. Radomski, and S.T. Davidge Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction Circ Res 87 2000 670 676
61. A. Martinez, H.R. Oh, E.J. Unsworth, C. Bregonzio, J.M. Saavedra, and W.G. Stetler-Stevenson Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator Biochem J 383 2004 413 418 (Pubitemid 39546110)
62. T.M. Camp, S.C. Tyagi, G.M. Aru, M.R. Hayden, J.L. Mehta, and S.C. Tyagi Doxycycline ameliorates ischemic and border-zone remodeling and endothelial dysfunction after myocardial infarction in rats J Heart Lung Transplant 23 2004 729 736 (Pubitemid 38721443)
63. J. Su, D.I. Palen, P.A. Lucchesi, and K. Matrougui Mice lacking the gene encoding for mmp-9 and resistance artery reactivity Biochem Biophys Res Commun 349 2006 1177 1181 (Pubitemid 44416385)
64. G.S. Butler, and C.M. Overall Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics Biochemistry 48 2009 10830 10845
65. S.F. Rodrigues, E.D. Tran, Z.B. Fortes, and G.W. Schmid-Schonbein Matrix metalloproteinases cleave the beta2-adrenergic receptor in spontaneously hypertensive rats Am J Physiol Heart Circ Physiol 299 2010 H25 H35
66. F. Barbosa Jr., R.F. Gerlach, and J.E. Tanus-Santos Matrix metalloproteinase-9 activity in plasma correlates with plasma and whole blood lead concentrations Basic Clin Pharmacol Toxicol 98 2006 559 564
67. E. Rizzi, M.M. Castro, K. Fernandes, F. Barbosa Jr., G.M. Arisi, and N. Garcia-Cairasco Evidence of early involvement of matrix metalloproteinase-2 in lead-induced hypertension Arch Toxicol 83 May (5) 2009 439 449
68. S.E. Greenwald Ageing of the conduit arteries J Pathol 211 2007 157 172 (Pubitemid 46195514)
69. C. Bouvet, S. Moreau, J. Blanchette, D. de Blois, and P. Moreau Sequential activation of matrix metalloproteinase 9 and transforming growth factor beta in arterial elastocalcinosis Arterioscler Thromb Vasc Biol 28 May (5) 2008 856 862 (Pubitemid 351544099)
70. S.M. Arribas, A. Hinek, and M.C. Gonzalez Elastic fibres and vascular structure in hypertension Pharmacol Ther 111 September (3) 2006 771 791 (Pubitemid 44118433)
71. P. Brassard, F. Amiri, and E.L. Schiffrin Combined angiotensin ii type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries Hypertension 46 September (3) 2005 598 606 (Pubitemid 41376842)
72. S.J. Zieman, V. Melenovsky, and D.A. Kass Mechanisms, pathophysiology, and therapy of arterial stiffness Arterioscler Thromb Vasc Biol 25 May (5) 2005 932 943 (Pubitemid 40627836)
73. A.M. Marcaccini, C.A. Meschiari, L.R. Zuardi, T.S. de Sousa, M. Taba Jr., and J.M. Teofilo Gingival crevicular fluid levels of mmp-8, mmp-9, timp-2, and mpo decrease after periodontal therapy J Clin Periodontol 37 2010 180 190
74. A.M. Marcaccini, A.B. Novaes Jr., C.A. Meschiari, S.L. Souza, D.B. Palioto, and C.A. Sorgi Circulating matrix metalloproteinase-8 (mmp-8) and mmp-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy Clin Chim Acta 409 2009 117 122
75. M.L. Martinez, E. Rizzi, M.M. Castro, K. Fernandes, L.M. Bendhack, and R.F. Gerlach Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats Eur J Pharmacol 599 2008 110 116
76. D. Yamamoto, S. Takai, and M. Miyazaki Inhibitory profiles of captopril on matrix metalloproteinase-9 activity Eur J Pharmacol 588 2008 277 279
77. D.L. Brown, K.K. Desai, B.A. Vakili, C. Nouneh, H.M. Lee, and L.M. Golub Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (midas) pilot trial Arterioscler Thromb Vasc Biol 24 2004 733 738 (Pubitemid 38451612)
78. J.B. Payne, L.M. Golub, J.A. Stoner, H. Lee, R.A. Reinhardt, T. Sorsa, and M.J. Slepian The effect of subantimicrobial-dose-doxycycline periodontal therapy on serum biomarkers of systemic inflammation: a randomized, double-masked, placebo-controlled clinical trial J Am Dent Assoc 142 2011 262 273